A multicultural group practicing yoga together in a bright studio

Sprout Health vs Strut Health: GLP-1 Comparison 2026

Sprout Health vs Strut Health: pricing, medication type, clinical support, and which budget-conscious GLP-1 patient each program fits. Both programs’ prices verified September 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated October 6, 20264 min read

Quick answer

Strut Health typically wins on sticker price for compounded GLP-1. Choose Strut Health if you're price-first; choose Sprout Health if you want brand-name (FDA-approved) access.

Side-by-side comparison

Feature	Sprout Health	Strut Health
Best for	Balance of price and clinical support	Low-cost compounded GLP-1 with plain compounding disclosures
Medication type	Compounded semaglutide and tirzepatide; brand-name Wegovy/Zepbound listed cash-pay	Compounded semaglutide and tirzepatide, sublingual/oral and once-weekly injection
Pricing model	12-month plan billed every 12 months, or a monthly plan billed every 4 weeks; Sprout states the same price at any dose (homepage, 2026-10-06)	Monthly auto-refill subscription; dose-tier 'starting at' entry pricing; medical-necessity gated
Semaglutide price	From $99/mo on the 12-month plan (billed $1,188 every 12 months); $149 per 4 weeks on the monthly plan; same price at any dose (compounded semaglutide, homepage-verified 2026-10-06)	Compounded, sublingual/oral from $99/mo, injectable from $129/mo (auto-refill 'starting at' entry-dose pricing; Strut prices injectable semaglutide differently across two live pages, $129 on struthealth.com/weight-loss/semaglutide vs $149 on struthealth.com/womens-weight-loss as of 2026-09-28, lower genuinely-purchasable figure cited per RY's pricing standard)
Tirzepatide price	From $149/mo on the 12-month plan (billed $1,788 every 12 months); $199 per 4 weeks on the monthly plan; same price at any dose (compounded tirzepatide, homepage-verified 2026-10-06)	Compounded, injectable from $149/mo (price cut from $199, re-verified 2026-09-28); oral lozenge from $199/mo (lozenge only if a GLP-1 injection fails or can't be used)
Key watchout	The $99 (semaglutide) and $149 (tirzepatide) figures are Sprout's 12-month plan rates, billed $1,188 and $1,788 every 12 months. The monthly plan is $149 (semaglutide) and $199 (tirzepatide) per 4 weeks, billed every 4 weeks, not per calendar month. Sprout states 'Same price at any dose.' Refund eligibility narrows once a provider has reviewed the intake (refund policy, read 2026-10-06).	Entry prices are the lowest-dose auto-refill rate, higher doses cost more, so confirm your dose at intake. Oral/sublingual and lozenge options require you to have failed or be unable to use an injectable GLP-1.
Price checked	Checked by a person October 6, 2026 · an automated check re-read it October 15, 2026	Checked by a person September 28, 2026 · an automated check re-read it October 15, 2026

When to choose Sprout Health

You want a low compounded entry price with provider visit, medication and shipping included
You want a stated flat price at every dose (Sprout's own homepage statement)
You're comfortable choosing between a 12-month plan billed every 12 months and a monthly plan billed every 4 weeks
You may want to escalate dose with the same provider over time

Check current Sprout Health pricing →

When to choose Strut Health

You want low-cost compounded semaglutide or tirzepatide with medication included
You value upfront 'compounded / not FDA-approved' disclosures and a PCAB-accredited pharmacy
You're comfortable with async-only care (no video visit) and a medical-necessity screen
You want to cancel, pause, or delay your subscription anytime

Check current Strut Health pricing →

Full reviews

Frequently asked questions

Is Sprout Health cheaper than Strut Health?

Neither Sprout Health nor Strut Health is uniformly cheaper, both publish dose-banded and formulation-banded pricing that depends on the exact product, dose, and any insurance pathway. Compare the specific tier you'd be on at each before deciding.

Which is better for semaglutide or tirzepatide, Sprout Health or Strut Health?

Both Sprout Health and Strut Health prescribe semaglutide and tirzepatide where appropriate. Choose based on how each program handles your target medication, not just the entry price.

Are Sprout Health and Strut Health compounded or brand-name?

Sprout Health offers compounded semaglutide and tirzepatide; brand-name wegovy/zepbound listed cash-pay. Strut Health offers compounded semaglutide and tirzepatide, sublingual/oral and once-weekly injection. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Sprout Health to Strut Health?

Yes, switching between Sprout Health and Strut Health is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Sprout Health and Strut Health to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like $99/mo on the 12-month plan (billed $1,188 every 12 months); $149 per 4 weeks on the monthly plan; same price at any dose (compounded semaglutide, homepage-verified 2026-10-06) and Compounded, sublingual/oral from $99/mo, injectable from $129/mo (auto-refill 'starting at' entry-dose pricing; Strut prices injectable semaglutide differently across two live pages, $129 on struthealth.com/weight-loss/semaglutide vs $149 on struthealth.com/womens-weight-loss as of 2026-09-28, lower genuinely-purchasable figure cited per RY's pricing standard) are starting tiers, not your guaranteed long-term cost.